In the News

Share
1669 News Items found
Article
A research working in an MSK lab
MSK Research Highlights, October 19, 2023
New MSK research examines how diabetes may speed the growth of multiple myeloma; analyzes the increasing number of patients who are benefiting from precision oncology; and highlights the unexpected role of the integrated stress response in response to genomic instability in mitochondrial DNA.
Mijin Kim seen working in laboratory.
Advice From a ‘Wunderkind’: Why MSK Is Great for Early Career Researchers
Learn why post-doctoral researcher Mijin Kim believes Memorial Sloan Kettering is an excellent choice for early career biomedical researchers, as she enjoys her recognition as a STAT Wunderkind, class of 2023.
Feature
Joanna Ihlo
Fighting Cancer on a Fixed Income: How MSK Helps Patients Cope With Financial Uncertainty
Learn how MSK helps patients navigate the intricacies of insurance and financial assistance throughout their cancer treatment.
Finding
Dr. Zsofia Stadler
Preventing Lynch Syndrome Cancers: New Study Suggests Immunotherapy Could Work
An analysis of patients with Lynch syndrome treated at MSK finds that immunotherapy drugs called checkpoint inhibitors may prevent serious tumors from forming.
MSK physician Dr. Deb Schrag
Experimental Blood Test for Cancer Shows Potential To Screen for Multiple Types Simultaneously
Learn how a blood test could someday provide a way to detect cancers at an early stage.
Q&A
Plastic and reconstructive surgeon Michelle Coriddi, MD
Implant vs. Flap Breast Reconstruction Surgery: How To Decide
Memorial Sloan Kettering plastic and reconstructive surgeon Michelle Coriddi describes breast reconstruction options for women undergoing mastectomy, including implants, flap surgery, TRAM flap, and DIEP flap, and more.
Family of four sitting and smiling for camera.
Living With Metastatic Breast Cancer: A Mother’s Story of Hope
Learn how MSK's expertise in metastatic breast cancer helped a mother celebrate a long-awaited milestone with her family.
Photo of Hispanic patient who had metaplastic breast cancer.
Expertise To Treat Metaplastic Breast Cancer From MSK’s Rare Breast Cancer Program
Patients like Michelle benefit from the specialized skills of experts in MSK’s Rare Breast Cancer Program.
Feature
Danielle Polumbo
How MSK Cares for People With Hereditary Breast Cancer: Danielle’s Story
Learn how Danielle has faced hereditary breast cancer caused by a BRCA1 gene mutation and had fewer side effects than traditional chemotherapy because of an experimental treatment at MSK.
Researchers Russell Kunes, Thomas Walle, and Dana Pe'er
MSK Researchers Develop New Open-Source Method To Improve Decoding of Single-Cell Data
MSK researchers have developed a new open-source computational method, dubbed Spectra, which improves the analysis of single-cell transcriptomic data — and made it freely available to researchers around the world.
Feature
Dr. Simon Powell
Advances From MSK Researchers Reported at 2023 ASTRO Meeting
Experts from MSK shared their work in more than 40 presentations and poster sessions at the 2023 meeting of ASTRO, the American Society for Therapeutic Radiology and Oncology.
Close up of gloved hands working in a lab
MSK Research Highlights September 29, 2023
New research from MSK develops a method for analyzing cancer cells that survive treatment for acute myeloid leukemia; identifies a transcription factor that orchestrates natural killer cell response; and finds vepafestinib is a promising therapeutic for the treatment of RET-driven cancers.
MSK breast cancer patient Marcia McFayden seen smiling outdoors.
Living Better During Cancer and Beyond: The MSK Healthy Living Program
Learn about the MSK Healthy Living program that provides breast cancer patients with a custom plan tailored to their needs to help with nutrition and exercise, integrative medicine; support for mental, emotional, and spiritual well-being and much more.
Dr. Teddy Yewdell presenting at the MSK Postdoc Slam and in front of the sign of his new employer, Genentech.
Training the Next Generation of Scientists: Meet 3 Remarkable MSK Alumni
At MSK, our goal is not just to train the scientists of tomorrow, but the scientific leaders.
Q&A
Imaging test
CT Scan Safety: A Radiation Reality Check
Medical physicist Lawrence Dauer explains what you should know about the use and safety of tests such as CT scans that use radiation to obtain images of the body.
MSK exercise scientist Lee Jones, PhD, is seen in a gym.
Does Exercise Improve Survival After a Cancer Diagnosis? An Encouraging New Study
Learn how exercise can help many people live longer after they are diagnosed with cancer, according to a new study led by MSK exercise scientist Lee Jones, Chief of the Exercise-Oncology Service.
MSK Kids patient Sammy preparing to swing a bat
MSK Earns Top Distinction for Pediatric Cancer Care From American College of Surgeons
Thanks to MSK’s expertise in treating young people with cancer, 15-year-old high school athlete Sammy is back to doing what he loves.
Three GSK students in a classroom
Gerstner Sloan Kettering Graduate Students Receive 2023-2024 Fellowships
Seven GSK PhD students were awarded nine competitive fellowships from prestigious external agencies such as the National Cancer Institute (NCI) and National Science Foundation (NSF).
Man and son selfie outdoors.
Experimental Approach Using MRI-Guided Radiation for Prostate Cancer Destroys Tumors With Great Precision
Learn how MSK doctors deliver intense doses of radiation with great precision using MRI guidance.
Q&A
Hematologic oncologist Eytan Stein and nurse practitioner Coleen Ranaghan consult with a patient.
How Acute Myeloid Leukemia Is Treated at MSK: An Interview With Eytan Stein
In this interview, hematologic oncologist Eytan Stein, Director of the Program for Drug Development in Leukemia, talks about the latest advances in treatment for AML and how people can benefit from receiving their treatment at MSK.